A carregar...
Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges
Chimeric antigen receptor (CAR) T-cell therapy is an innovative form of immunotherapy wherein autologous T-cells are genetically modified to express chimeric receptors encoding an antigen-specific single-chain variable fragment and costimulatory molecules. Moreover, CAR T-cell therapy can only work...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797648/ https://ncbi.nlm.nih.gov/pubmed/33442419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.54095 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|